CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
High real-world efficacy of elbasvir/grazoprevir (EBR/GZR) in genotype 1 (GT1) infected patients with and without liver cirrhosis: results from the German Hepatitis C Registry (DHC-R)
DOI 10.1055/s-0038-1677260
Bibliografische Angaben
Nachweis in CareLit
Autor:innenH Hinrichsen, H Klinker, A Stoehr, C John, R Heyne, G Klausen, KG Simon, M Cornberg, M Kuhn, U Naumann, M Bilzer, V Guenther, V Witte, S Zeuzem
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe01/2019
Jahrgang / SeitenJg. 57
Kernaussage aus der Literatur
Abstract-Vorschau
High real-world efficacy of elbasvir/grazoprevir (EBR/GZR) in genotype 1 (GT1) infected patients with and without liver cirrhosis: results from the German Hepatitis C Registry (DHC-R)
Zitieren
Zitierempfehlung
H Hinrichsen, H Klinker, A Stoehr, C John, R Heyne, G Klausen, KG Simon, M Cornberg, M Kuhn, U Naumann, M Bilzer, V Guenther, V Witte, S Zeuzem (2019) High real-world efficacy of elbasvir/grazoprevir (EBR/GZR) in genotype 1 (GT1) infected patients with and without liver cirrhosis: results from the German Hepatitis C Registry (DHC-R). Zeitschrift für Gastroenterologie, 57 (01). https://doi.org/10.1055/s-0038-1677260
Mit CareLit weiterarbeiten